USC(SH:688403)2025-04-29 15:53Financial Performance - The company's operating revenue for Q1 2025 was CNY 374,578,911.73, representing an increase of 18.80% compared to CNY 315,302,067.12 in the same period last year[3]. - Net profit attributable to shareholders was CNY 40,588,834.35, a significant increase of 54.17% from CNY 26,327,629.49 year-on-year[3]. - The net profit after deducting non-recurring gains and losses was CNY 34,181,714.67, up 53.23% from CNY 22,307,774.13 in the previous year[3]. - Operating profit for Q1 2025 was CNY 44,527,779.12, up 67.0% from CNY 26,668,562.32 in Q1 2024[16]. - Basic and diluted earnings per share were both CNY 0.05, representing a 66.67% increase from CNY 0.03 in the same period last year[3]. - Net profit attributable to shareholders for Q1 2025 was CNY 40,588,834.35, representing a 54.3% increase compared to CNY 26,327,629.49 in Q1 2024[17]. Cash Flow - The net cash flow from operating activities reached CNY 150,299,217.76, an increase of 30.58% compared to CNY 115,101,149.97 in the same period last year[3]. - Operating cash flow for Q1 2025 was CNY 150,299,217.76, an increase of 30.6% from CNY 115,101,149.97 in Q1 2024[20]. - Cash inflow from investment activities in Q1 2025 totaled CNY 583,790,779.44, significantly higher than CNY 40,658,019.86 in Q1 2024[20]. - The company reported a net cash outflow from investment activities of CNY 110,927,663.71 in Q1 2025, compared to a net outflow of CNY 188,931,547.70 in Q1 2024[20]. - Net cash flow from financing activities was -1,003,005.40, compared to 31,627,648.82 in the previous period[22]. - Total cash inflow from financing activities amounted to 121,693,379.43[22]. - Cash outflow related to financing activities totaled 90,065,730.61[22]. - The ending balance of cash and cash equivalents reached 192,966,949.06, up from 69,686,235.09 year-over-year[22]. - Cash and cash equivalents increased to RMB 193,968,354.73 from RMB 159,667,616.07, representing a growth of about 21.5%[12]. - Cash inflow related to exchange rate changes on cash and cash equivalents was 2,560,162.31[22]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 4,663,024,907.97, reflecting a 1.56% increase from CNY 4,591,223,702.62 at the end of the previous year[4]. - Total liabilities as of the end of the reporting period were CNY 1,414,978,937.12, compared to CNY 1,390,152,781.99 at the end of the previous period[16]. - The company's current liabilities included accounts payable of RMB 142,409,075.46, up from RMB 131,897,320.53, reflecting an increase of approximately 7.6%[13]. - The total current assets reached RMB 1,689,645,384.94, compared to RMB 1,610,392,728.27, marking an increase of approximately 4.9%[12]. - The company reported a significant increase in contract liabilities, rising to RMB 16,797,391.14 from RMB 1,718,686.09, a substantial growth of about 877.5%[13]. Research and Development - Research and development expenses totaled CNY 23,936,801.41, which is 6.39% of operating revenue, up from 6.05% in the previous year[3]. - Research and development expenses for Q1 2025 were CNY 23,936,801.41, up from CNY 19,075,163.79 in Q1 2024[16]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 20,437, with the largest shareholder holding 20.78% of the shares[7]. - Total equity attributable to shareholders increased to CNY 3,248,045,970.85 from CNY 3,201,070,920.63[16]. Other Information - The company has not disclosed any significant changes in the shareholding structure or related party transactions during the reporting period[10]. - There were no significant updates regarding new product developments or market expansion strategies mentioned in the conference call[11]. - The company does not plan to adopt new accounting standards starting from 2025[23].